Hepatotoxicity and complementary and alternative medicines

Clinics in Liver Disease

Volumn 7, Issue 2, 2003, Pages 453-473

  Schiano, Thomas D ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACKEE EXTRACT; ATRACTYLIS GUMMIFERA EXTRACT; AZADIRACHTA INDICA EXTRACT; BAJAIAOLIAN EXTRACT; BERBERIS VULGARIS EXTRACT; CALLILEPSIS LAUREOLA EXTRACT; CAMPHOR; CASCARA SAGRADA; CASSIA ANGUSTIFOLIA EXTRACT; CHELIDONIUM EXTRACT; COCA EXTRACT; CROTALARIA EXTRACT; EPHEDRA SINICA EXTRACT; HEDEOMA PULEGOIDES EXTRACT; HELIOTROPIUM EXTRACT; HERBACEOUS AGENT; ISABGOL EXTRACT; KAVA; KOMBUCHA EXTRACT; LARREA TRIDENTATA EXTRACT; LIPOKINETICS EXTRACT; LIPOKINETIX; LYCOPODIUM SERRATUM EXTRACT; MENTHA PULEGIUM EXTRACT; METHYLAZOXYMETHANOL GLUCOSIDE; NATURAL PRODUCT; PLANT EXTRACT; POLYGONUM MULTIFORUM EXTRACT; SENECIO EXTRACT; TEUCRIUM CHAMAEDRYS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENENCAPSAN; XIAO CHAI HU TANG;

ACKEE; ALTERNATIVE MEDICINE; ATRACTYLIS GUMMIFERA; AZADIRACHTA INDICA; BAJIAOLIAN; CALLILEPSIS LAUREOLA; CASSIA ANGUSTIFOLIA; CHELIDONIUM; CHINESE MEDICINE; CHRONIC LIVER DISEASE; COCA; COMFREY; COPALTRA; COPTIS CHINENSIS; CROTALARIA; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG MANUFACTURE; DRUG MARKETING; DRUG MECHANISM; DRUG SAFETY; EPHEDRA SINICA; FRUIT; HEDEOMA PULEGOIDES; HELIOTROPIUM; HERBAL MEDICINE; HUMAN; ISABGOL; LARREA TRIDENTATA; LIVER TOXICITY; LYCOPODIUM; MENTHA PULEGIUM; MUSHROOM; NONHUMAN; PATIENT EDUCATION; PLANT; POLYGONUM; POLYGONUM MULTIFORUM; REVIEW; SASSAFRAS ALBIDUM; SENECIO; SEUTELLARIA; SHARK; SHARK CARTILAGE; STANDARDIZATION; TEA; TEUCRIUM POLIUM; TU SAN CHI; TUSSILAGO FARFARA; VALERIANA OFFICINALIS;

EID: 0037998850     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(03)00030-8     Document Type: Review

References (97)

1. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451.
2. Schuppan D, Jian J-D, Brinkhaus B, et al. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999;30:1099.
3. Kao WF, Hung DZ, Tsai WJ, et al. Podophyllotoxin intoxication: toxic effect of Bajiaolian on herbal therapuetics. Hum Exp Toxicol 1992;11:480.
4. UCA, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J 2000;93:596.
5. Lin YF, Lin SH. Simultaneous acute renal and hepatic failure after ingesting raw carp gall bladder. Nephrol Dial Transplant 1999;14:2011.
6. Mallat A, Dhumeaux D. Cocaine and the liver. J Hepatol 1991;12:275.
7. Wurtz A-S, Vial T, Isoard B, et al. Possible hepatotoxicity from Copaltra, an herbal medicine. Ann Pharmacother 2002;36:941.
8. Fraquelli M, Colli A, Cocciolo M, et al. Adult syncytial giant cell chronic hepatitis due to herbal remedy. J Hepatol 2000;33:505.
9. Roulet M, Laurini R, Rivier L, et al. Hepatic veno-occlusive disease in newbom infant of a woman drinking herbal tea. J Pediatr 1988;112:433.
10. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002;22:195.
11. Segelman AB, Segelman FP, Karliner J, et al. Sassafras and herb tea. Potential health hazards. JAMA 1976;236:447.
12. Ashar B, Vargo E. Shark cartilage-induced hepatitis. Ann Intern Med 1996;125:780.
13. DeSmet PAGM, Van den Eertwegh, et al. Hepatotoxicity associated with herbal tablets. BMJ 1996;313:92.
14. Chitturi S, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000;15:1093.
15. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med 1993;328:246.
16. Huxtable RJ. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 1992;117:165.
17. Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262.
18. Seeff LB, Lindsay KL, Bacon BR, et al. Complementary and alternative medicine in chronic liver disease. Hepatology 2001;34:595.
19. Bartels CL, Miller SJ. Herbal and related remedies. NCP 1998;13:5.
20. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med 2002;136:42.
21. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998;104:170.
22. Kaplowitz N. Hepatotoxicity of hcrbal remedies: Insights into the intricacies of plant-animal welfare and cell death. Gastroenterology 1997;113:1408.
23. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26:47.
24. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 2000;280:1569.
25. Carlsson C. Herbs and hepatitis. Lancet 1990;2:1068.
26. Phillips LG, Nichols MH, King WD. Herbs and HIV. South Med J 1995;88:911.
27. Zimmerman HJ, Ishak KG. General aspects of drug-induced liver disease. Gastroenterol Clin N Amer 1995;24:739.
28. Zimmerman HJ, Lewis JH. Chemical- and toxin-induced hepatotoxicity. Gastroenterol Clin North Am 1995;24:1027.
29. McGee J, Patrick RS, Wood CB, et al. A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption. J Clin Path 1976;29:788.
30. Tandon HD, Tandon BN, Ramalingaswami V. Epidemic of toxic hepatitis in India of possible mycotoxic origin. Arch Pathol Lab Med 1978;10-2:372.
31. Bras G, Jelliffe DB, Stuart KL. Veno-occlusive disease of liver with nonportal type of cirrhosis occurring in Jamaica. Arch Path 1954;57:285.
32. Valla D, Benhamou JP. Drug-induced vascular and sinusoidal lesions of the liver. Clin Gastroenterol 1988;2:481.
33. Ridker PM, Ohkuma S, McDermott WV, et al. Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985;88:1050.
34. DeLeve L, Wang X, Kuhlenkamp J, et al. Selective toxicity to sinusoidal endothelial cells by agents that cause hepatic venoocclusive disease is modulated by GSH: azathioprine and monocrotaline. Hepatology 1996;23:589.
35. Huxtable RJ. New aspects of the toxicology and pharmacology of pyrrolizidine alkaloids. Mol Pharmacol 1979;10:159.
36. Mattocks AR. Toxicity of pyrrolizidine alkaloids. Nature 1968;217:723.
37. Bach N, Thung SN, Schaffner F. Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med 1989;87:97.
38. Ridker PM, McDermott V. Comfrey herb tea-induced hepatic veno-occlusive disease. Lancet 1989;7:657.
39. Stillman AE, Huxtable R, Consroe P, et al. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology 1977;73:349.
40. Gordon DW, Rosenthal G, Hart J, et al. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal mediations. JAMA 1995;273:489.
41. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991;151:2281.
42. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997;157:913.
43. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chaemaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129.
44. Lekehal M, Pcssayre D, Lereau JM, et al. Hepatotoxicity of the herbal medicine, germander. Metabolic activation of its furano dierpenoids by cytochrome P4503A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996;24:212.
45. Loeper J, Descatoire V, Lctteron P, et al. Hepatotoxicity of germander in mice. Gastroenterology 1994;106:646.
46. Fau D, Lekehal M, Farrell G, et al. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997;113:1334.
47. DeBerardinis V, Moulis C, Maurice M, et al. Human microsomal epoxide hydrolase is the target of germander-induced autoantibodies on the surface of human hepatocytes. Mol Pharmacol 2000;58:542.
48. Mattei A, Rucay P, Samuel D, et al. Liver transplantation for severe acute liver failure after herbal medicine (teucrium polium) administration. J Hepatol 1995;22:597.
49. Anderson IB, Mullen WH, Mecker JE, et al. Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996;124:726.
50. Madyastha KM, Raj CP. Biotransformations of R-(+)pulegone and menthofuran in vitro: Chemical basis for toxicity. Biochem Biophys Res Commun 1990;173:1086.
51. McClananhan RH, Thomassen D, Slattery JT, et al. Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins. Chem Res Toxicol 1989;2:349.
52. Thomassen D, Slattery JT, Nelson SD. Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: Roles of glutathione. J Pharmacol Exp Ther 1990;253:567.
53. Georgiou M, Sianidou L, Hatzis T, et al. Hepatotoxicity due to Atractylis gummifera-L. Clin Toxicol 1988;26:487.
54. Hedili A, Wamet JM, Thevenin M, et al. Biochemical investigation of Atractylis gummifera-L hepatotoxicity in the rat. Arch Toxicol 1989;13:312.
55. Stewart MJ, Steenkamp V. The biochemistry and toxicity of atractyloside: a review. Ther Drug Monit 2000;22:641.
56. Mokhobo KP. Herbs use and necro-degenerative hepatitis. S Afr Med J 1976;50:1096.
57. Harvey J, Colin-Jones DG. Mistletoe hepatitis. BMJ 1981;282:186.
58. MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. BMJ 1989;299:1156.
59. Haouzi D, Lekehal M, Moreau A, et al. Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation and apoptosis in rat hepatocytes. Hepatology 2000;32:303.
60. Campo JV, McNabb J, Perel JM, et al. Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry 2002;41:6.
61. Escher M, Desmeules J. Hepatitis associated with Kava, an herbal remedy. BMJ 2001;322:139.
62. Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity. Ann Intern Med 2001;135:68.
63. Chan TYK, Chan JCN, Tomlinson B, et al. Chinese herbal medicines revisited: A Hong Kong perspective. Lancet 1993;342:1532.
64. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs: Possible toxic components. Gut 1995;36:146.
65. Tomlinson B, Chan TYK, Chan JCN, et al. Herb-induced acontine poisoning. Lancet 1993;341:370.
66. Melchart D, Linde K, Weidenhammer W, et al. Liver enzyme elevation in patients treated with traditional Chinese medicine. JAMA 1999;282:28.
67. Graham-Brown R. Toxicity of Chinese herbal remedies. Lancet 1992;340:673.
68. Penharic-Walton L, Murray V. Toxicity of Chinese herbal remedies. Lancet 1992;340:674.
69. Yoshida EM, McLean CA, Cheng ES, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol 1996;91:2647.
70. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002;252:107.
71. Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997;37:334.
72. McRae CA, Agarwal K, Mutimer D, et al. Hepatitis associated with Chinese herbs. Eur J Gastroenterol Hepatol 2002;14:559.
73. Nadir A, Agrawal S, King PD, et al. Acute hepatitis associated with the use of a Chinese herbal product, Ma-huang. Am J Gastroenterol 1996;91:1436.
74. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-Wu-Pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996;38:280.
75. Park GJ-H, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001;16:115.
76. Woolf GM, Petrovic LM, Rotjer SE, et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994;121:729.
77. Young CY. Neonatal hyperbilirubinemia in Chinese. Trop Geogr Med 1973;25:151.
78. Horowitz RS, Dart RC, Gomez H, et al. Jin Bu Huan toxicity in children - Colorado, 1993. MMWR Morb Mortal Wkly Rep 1993;42:633,
79. Horowitz RS, Feldhaus K, Dart RC, et al. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med 1996;156:899.
80. Itoh S, Marutani K, Nishijima T, et al. Liver injuries induced by herbal medicine, Syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995;40:1845.
81. Yamashiki M, Nishimura A, Suzuki H, et al. Effects of the Japanese herbal medicine "Sho-saikoto" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C. Hepatology 1997;25:1390.
82. Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997;92:703.
83. Benninger J, Schneider HT, Schuppan D, et al. Acute hepatitis induced by greater celandine (chelidonium majus). Gastroenterology 1999;117:1234.
84. Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with the dietary supplement lipokinetix. Ann Intern Med 2002;136:590.
85. Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of prostata. Ann Intern Med 1997;127:169.
86. Beuers U, Splengler U, Pape GR. Hepatitis after chronic abuse of senna. Lancet 1991;337:372,
87. Nadir A, Reddy D, Van Thiel DH, Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 2000;95:3634.
88. Perron AD, Patterson JA, Yanofsky NN. Kombucha "mushroom" hepatotoxicity. Ann Emerg Med 1995;26:660.
89. Hirono I, Kachi H, Kato T. A survey of acute toxicity of cycads and mortality rate from cancer in the Miyako Islands. Okinawa. Acta Path Jap 1970;20:327.
90. Tanaka K, Kean EA, Johnson B. Jamaican vomiting sickness. Biochemical investigation of two cases. N Engl J Med 1976;195:461.
91. Fugh-Berman A. Herb-drug interaction. Lancet 2000;355:134.
92. Barone GW, Gurley BJ, Ketel BL, et al. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation 2001;71:239.
93. Moore LB, Goodwin B, Jones SA, et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 2000;97:7500.
94. Bailey DG, Arnold JMD, Spencc JD. Grapefruit juice and drugs: how significant is the interaction? Clin Pharmacol 1994;26:91.
95. Miller LG. Herbal medicinals. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200.
96. Homma M, Oka K, Ikeshima K, et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995;47:687.
97. Ang-Lee MK, Moss J, Yuan C-S. Herbal medicines and perioperative care. JAMA 2001;286:208.